ARCHIVES

Industry Groups Lobby for Lower Standards for FDA Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

ACS Issues Challenge To cut Death Rate From Cancer In Half

November 22, 1996

In Brief: Nutrition Research Intrigues Investigators After All; Advisory Committee Being Formed

March 7, 1975

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Cooperative Groups Cut In On $1 Million Head 7 Neck Projects

March 25, 1977

US Oncology Clarifies Role of Pharmacy Committee

January 24, 2003

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988